Loading clinical trials...
Loading clinical trials...
A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Kowa Research Institute, Inc.
NCT07024693 · Fuchs Endothelial Corneal Dystrophy, Fuchs
NCT04440280 · Fuchs Endothelial Corneal Dystrophy
NCT06966167 · Fuchs Endothelial Corneal Dystrophy, Cataract
NCT06425666 · Cataract Surgery, Cataract and Fuchs Endothelial Corneal Dystrophy
NCT07217249 · Fuchs Endothelial Corneal Dystrophy, Corneal Endothelial Decompensation
Keck Hospital of USC
Los Angeles, California
Macy Eye Center
Los Angeles, California
Jules Stein Eye Institute
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions